Share chart Quidel
Extended chart
Simple chart
About Quidel
Quidel Corporation - крупный американский производитель диагностических медицинских продуктов, которые продаются по всему миру. 8 мая 2020 года Управление по санитарному надзору за качеством пищевых продуктов и медикаментов США (FDA) выдало первое разрешение на использование в экстренных случаях (EUA) для теста на антиген COVID-19, новой категории тестов для использования в условиях продолжающейся пандемии. Эти диагностические тесты быстро обнаруживают фрагменты белков, обнаруженных на вирусе или внутри него, путем тестирования образцов, взятых из носовой полости, с помощью мазков.| IPO date | 1991-02-01 |
|---|---|
| ISIN | US2197981051 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.quidel.com |
| Цена ао | 39.94 |
| Change price per day: | 0% (39.94) |
|---|---|
| Change price per week: | -5.13% (42.1) |
| Change price per month: | -2.82% (41.1) |
| Change price per 3 month: | +2.52% (38.96) |
| Change price per half year: | -11.15% (44.95) |
| Change price per year: | -9.19% (43.98) |
| Change price per 3 year: | -64.43% (112.3) |
| Change price per 5 year: | -79.53% (195.12) |
| Change price per 10 year: | +121.89% (18) |
| Change price per year to date: | -10.41% (44.58) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Carlyle Group Inc. | 12460183 | 18.63 |
| T. Rowe Price Investment Management, Inc. | 8698143 | 13.01 |
| Vanguard Group Inc | 4841410 | 7.24 |
| Blackrock Inc. | 4798164 | 7.17 |
| Senvest Management LLC | 2999353 | 4.48 |
| ArrowMark Colorado Holdings LLC | 2663606 | 3.98 |
| State Street Corporation | 1530817 | 2.29 |
| JP Morgan Chase & Company | 1335012 | 2 |
| Burgundy Asset Management Ltd. | 1161485 | 1.74 |
| Rubric Capital Management LP | 980063 | 1.47 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Amplify Treatments Testing and Advancements ETF | 3.55 | 10.31 | 1.06 |
| iShares Morningstar Small Cap Value ETF | 0.10014 | 26.7 | 2.50476 |
| iShares Morningstar Small-Cap Value ETF | 0.10014 | 201.65 | 2.50476 |
| iShares ESG Aware MSCI USA Small-Cap ETF | 0.05244 | 18.09 | 1.49366 |
| iShares Morningstar Small-Cap ETF | 0.04986 | 30.1 | 1.60498 |
| iShares Morningstar Small-Cap ETF | 0.04986 | 391.25 | 1.60498 |
| iShares Russell 2500 ETF | 0.03866 | 18.06 | 1.58987 |
| iShares Russell Mid-Cap Value ETF | 0.02828 | 18.01 | 2.03934 |
iShares Russell Midcap ETF
|
0.02091 | 20.77 | 1.71565 |
iShares Russell 1000 Value ETF
|
0.01059 | 17.45 | 2.15361 |
| iShares Russell 3000 ETF | 0.00445 | 24.83 | 1.43482 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Robert J. Bujarski J.D. | Executive VP & COO | 2.62M | 1969 (56 years) |
| Dr. Werner Kroll Ph.D. | Senior Vice President of Research & Development | 1.25M | 1957 (68 years) |
| Mr. Joseph M. Busky CPA | Chief Financial Officer | 1.47M | 1968 (57 years) |
| Mr. Michael S. Iskra | Executive VP & Chief Commercial Officer | N/A | 1970 (55 years) |
| Mr. William J. Ferenczy | Point of Care Business Unit Leader | N/A | 1956 (69 years) |
| Ms. Tamara A. Ranalli | Molecular Diagnostics Business Unit Leader | N/A | 1973 (52 years) |
| Mr. Brian J. Blaser | President, CEO & Director | 1965 (60 years) | |
| Ms. Juliet C. Cunningham | Vice President of Investor Relations | ||
| Ms. Michelle A. Hodges J.D. | Senior VP, General Counsel & Corporate Secretary | 1963 (62 years) | |
| Mr. Ronald Lee Bowman | Chief Human Resources Officer |
Address: United States, San Diego, CA , 9975 Summers Ridge Road - open in Google maps, open in Yandex maps
Website: http://www.quidel.com
Website: http://www.quidel.com
